This is the list of the largest public listed companies in the Healthcare sector from the United States by market capitalization with links to their reference stock and industry.
Company Profile:
Seer, Inc.
Market Cap (USD):
$116.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Atossa Therapeutics, Inc.
Market Cap (USD):
$116.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Emergent BioSolutions Inc.
Market Cap (USD):
$114.1 M
Country:
United States
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
BioAtla, Inc.
Market Cap (USD):
$114.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Kinnate Biopharma Inc.
Market Cap (USD):
$113.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Armata Pharmaceuticals Inc.
Market Cap (USD):
$112.4 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Solid Biosciences Inc.
Market Cap (USD):
$111.6 M
Country:
United States
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
Eton Pharmaceuticals, Inc.
Market Cap (USD):
$111.4 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
NGM Biopharmaceuticals, Inc.
Market Cap (USD):
$110.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
ChromaDex Corporation
Market Cap (USD):
$109.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Catabasis Pharmaceuticals, Inc.
Market Cap (USD):
$109.5 M
(June 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Athira Pharma, Inc.
Market Cap (USD):
$109.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Inotiv, Inc.
Market Cap (USD):
$109.1 M
Country:
United States
Sector:
Healthcare
Industry:
Diagnostics & Research
Company Profile:
Cyteir Therapeutics, Inc.
Market Cap (USD):
$109.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
DiaMedica Therapeutics Inc.
Market Cap (USD):
$108.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Opiant Pharmaceuticals, Inc.
Market Cap (USD):
$107.5 M
(Jan. 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Isoray, Inc.
Market Cap (USD):
$107.0 M
(April 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Company Profile:
MariMed, Inc.
Market Cap (USD):
$105.3 M
Country:
United States
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
Galectin Therapeutics, Inc.
Market Cap (USD):
$105.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Leap Therapeutics, Inc.
Market Cap (USD):
$105.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Personalis, Inc.
Market Cap (USD):
$104.9 M
Country:
United States
Sector:
Healthcare
Industry:
Diagnostics & Research
Company Profile:
Entasis Therapeutics Holdings Inc.
Market Cap (USD):
$104.8 M
(July 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Adicet Bio, Inc.
Market Cap (USD):
$104.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Nektar Therapeutics
Market Cap (USD):
$102.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Jounce Therapeutics, Inc.
Market Cap (USD):
$101.6 M
(May 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
CytomX Therapeutics, Inc.
Market Cap (USD):
$101.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Corvus Pharmaceuticals, Inc.
Market Cap (USD):
$101.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Repro Med Systems, Inc.
Market Cap (USD):
$100.9 M
Country:
United States
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Company Profile:
Relmada Therapeutics, Inc.
Market Cap (USD):
$99.9 M
Country:
United States
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
Outlook Therapeutics, Inc.
Market Cap (USD):
$99.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology